[[abstract]]Dipeptide derivatives bearing various P2 residues and pyrrolidine derivatives as P1 mimics were evaluated in order to identify lead structures for the development of DPP8 and DPP9 inhibitors. Structure activity-relationship data obtained in this way led to the preparation of a series of alpha-aminoacyl ((2S, 4S)-4-azido-2-cyanopyrrolidines). These compounds were shown to be nanomolar DPP8/9 inhibitors with modest overall selectivity toward DPP IV and DPP II
The synthesis and structure-activity relationships of novel dipeptidyl peptidase IV inhibitors repla...
[[abstract]]A series of trans-2-aryl-cyclopropylamine derived compounds were synthesized and evaluat...
[[abstract]]A series of substituted pyrrolidine-2,4-dicarboxylic acid amides were synthesized as pot...
[[abstract]]Dipeptide derivatives bearing various P2 residues and pyrrolidine derivatives as P1 mimi...
[[abstract]]Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were...
[[abstract]]To find potent and selective inhibitors of dipeptidyl peptidase IV (DPP-IV), we synthesi...
[[abstract]]To obtain selective and potent inhibitors of dipeptidyl peptidases 8 and 9, we synthesiz...
[[abstract]]A series of (2S)-cyanopyrrolidines with glutamic acid derivatives at the P2 site have be...
[[abstract]]A series of 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-...
[[abstract]]Dipeptide-derived compounds, bearing various P2 residues and a diaryl pyrrolidin-2-yl ph...
Abstract: Vildagliptin is a marketed DPP4 inhibitor, used in the management of type 2 diabetes. The ...
[[abstract]]This work represents the first directed study to identify modification points in the top...
to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV...
[[abstract]]Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a new type of antidia...
[[abstract]]DPP8 is a prolyl dipeptidase homologous to DPP-IV, which is a drug target for Type 11 di...
The synthesis and structure-activity relationships of novel dipeptidyl peptidase IV inhibitors repla...
[[abstract]]A series of trans-2-aryl-cyclopropylamine derived compounds were synthesized and evaluat...
[[abstract]]A series of substituted pyrrolidine-2,4-dicarboxylic acid amides were synthesized as pot...
[[abstract]]Dipeptide derivatives bearing various P2 residues and pyrrolidine derivatives as P1 mimi...
[[abstract]]Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were...
[[abstract]]To find potent and selective inhibitors of dipeptidyl peptidase IV (DPP-IV), we synthesi...
[[abstract]]To obtain selective and potent inhibitors of dipeptidyl peptidases 8 and 9, we synthesiz...
[[abstract]]A series of (2S)-cyanopyrrolidines with glutamic acid derivatives at the P2 site have be...
[[abstract]]A series of 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-...
[[abstract]]Dipeptide-derived compounds, bearing various P2 residues and a diaryl pyrrolidin-2-yl ph...
Abstract: Vildagliptin is a marketed DPP4 inhibitor, used in the management of type 2 diabetes. The ...
[[abstract]]This work represents the first directed study to identify modification points in the top...
to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV...
[[abstract]]Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a new type of antidia...
[[abstract]]DPP8 is a prolyl dipeptidase homologous to DPP-IV, which is a drug target for Type 11 di...
The synthesis and structure-activity relationships of novel dipeptidyl peptidase IV inhibitors repla...
[[abstract]]A series of trans-2-aryl-cyclopropylamine derived compounds were synthesized and evaluat...
[[abstract]]A series of substituted pyrrolidine-2,4-dicarboxylic acid amides were synthesized as pot...